Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human interleukin 4.

J Banchereau1, T Defrance, J P Galizzi

  • 1Schering-Plough, Laboratory for Immunological Research, Dardilly, France.

Bulletin Du Cancer
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficiency of the traditional practice of traps to stimulate black truffle production, and its ecological mechanisms.

Scientific reports·2022
Same author

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162].

Redox biology·2017
Same author

Glycation stimulates cutaneous monocyte differentiation in reconstructed skin in vitro.

Mechanisms of ageing and development·2017
Same author

Resampling: An improvement of importance sampling in varying population size models.

Theoretical population biology·2016
Same author

How the truffle got its mate: insights from genetic structure in spontaneous and planted Mediterranean populations of Tuber melanosporum.

Molecular ecology·2016
Same author

In vitro Activation of B-CLL Cells.

Leukemia & lymphoma·2016
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
Same journal

[Robotics in oncological surgery].

Bulletin du cancer·2026
See all related articles

Human Interleukin-4 (IL-4) is a key cytokine produced by T cells. It influences various immune cells and plays a critical role in IgE production, with potential therapeutic applications.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Human Interleukin-4 (IL-4) is a pleiotropic cytokine secreted by activated T cells.
  • IL-4 affects a wide range of cells, including lymphocytes, monocytes, and endothelial cells.
  • Its function is modulated by the cytokine environment, with antagonistic effects observed with IL-2 and interferon gamma.

Purpose of the Study:

  • To elucidate the role of human IL-4 in immune responses.
  • To characterize the human IL-4 receptor.
  • To explore the potential therapeutic applications of IL-4.

Main Methods:

  • In vitro and in vivo experiments in mouse models.
  • In vitro experiments in human subjects.
  • Characterization of the IL-4 receptor binding affinity and composition.

Related Experiment Videos

Main Results:

  • IL-4 is crucial for the induction of Immunoglobulin E (IgE) production, an effect counteracted by interferons.
  • Human IL-4 binds to a high-affinity receptor.
  • The receptor is composed of at least one 130-kDa glycoprotein (800 AA), belonging to the hematopoietin receptor superfamily.

Conclusions:

  • Human IL-4 is a significant cytokine with diverse cellular targets and functions.
  • IL-4's role in IgE production is well-established, with interferons acting as antagonists.
  • The IL-4 receptor is a key component of the hematopoietin receptor superfamily, suggesting potential for IL-4 as an antitumoral and anti-inflammatory agent.